{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:01:08Z","timestamp":1790758868643,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T00:00:00Z","timestamp":1696204800000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870166"],"award-info":[{"award-number":["81870166"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.heliyon.2023.e20612","type":"journal-article","created":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T06:47:59Z","timestamp":1696402079000},"page":"e20612","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["POEMS syndrome in the 21st century: A bibliometric analysis"],"prefix":"10.1016","volume":"9","author":[{"given":"Fangrong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhimin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanyi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1319-4938","authenticated-orcid":false,"given":"Yunfeng","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.heliyon.2023.e20612_bib1","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1212\/WNL.34.6.712","article-title":"The Crow-Fukase syndrome: a study of 102 cases in Japan","volume":"34","author":"Nakanishi","year":"1984","journal-title":"Neurology"},{"issue":"4996","key":"10.1016\/j.heliyon.2023.e20612_bib2","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1136\/bmj.2.4996.802","article-title":"Peripheral neuritis in myelomatosis","volume":"2","author":"Crow","year":"1956","journal-title":"Br. Med. J."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e20612_bib3","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/00005792-198007000-00006","article-title":"Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes: the POEMS syndrome. Report on two cases and a review of the literature","volume":"59","author":"Bardwick","year":"1980","journal-title":"Medicine (Baltim.)"},{"issue":"10","key":"10.1016\/j.heliyon.2023.e20612_bib4","doi-asserted-by":"crossref","first-page":"e975","DOI":"10.1212\/WNL.0000000000008062","article-title":"Prevalence, clinical profiles, and prognosis of POEMS syndrome in Japanese nationwide survey","volume":"93","author":"Suichi","year":"2019","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.heliyon.2023.e20612_bib5","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.blre.2007.07.004","article-title":"POEMS syndrome","volume":"21","author":"Dispenzieri","year":"2007","journal-title":"Blood Rev."},{"issue":"17","key":"10.1016\/j.heliyon.2023.e20612_bib6","doi-asserted-by":"crossref","first-page":"4663","DOI":"10.1182\/blood-2011-06-362392","article-title":"The utility of plasma vascular endothelial growth factor levels in the diagnosis and follow-up of patients with POEMS syndrome","volume":"118","author":"D'Souza","year":"2011","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.heliyon.2023.e20612_bib7","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2169\/internalmedicine.46.6246","article-title":"Failure of treatment with anti-VEGF monoclonal antibody for long-standing POEMS syndrome","volume":"46","author":"Kanai","year":"2007","journal-title":"Intern Med"},{"issue":"12","key":"10.1016\/j.heliyon.2023.e20612_bib8","doi-asserted-by":"crossref","first-page":"4972","DOI":"10.1182\/blood-2005-12-5045","article-title":"Bevacizumab therapy for POEMS syndrome","volume":"107","author":"Straume","year":"2006","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e20612_bib9","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1093\/annonc\/mdm602","article-title":"Bevacizumab therapy before autologous stem-cell transplantation for POEMS syndrome","volume":"19","author":"Dietrich","year":"2008","journal-title":"Ann. Oncol."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e20612_bib10","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1182\/blood-2005-03-0910","article-title":"Bevacizumab therapy for POEMS syndrome","volume":"106","author":"Badros","year":"2005","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.heliyon.2023.e20612_bib11","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/bmt.2008.381","article-title":"Successful combination treatment with bevacizumab, thalidomide and autologous PBSC for severe POEMS syndrome","volume":"43","author":"Ohwada","year":"2009","journal-title":"Bone Marrow Transplant."},{"issue":"7","key":"10.1016\/j.heliyon.2023.e20612_bib12","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1002\/ajh.26240","article-title":"POEMS syndrome: 2021 Update on diagnosis, risk-stratification, and management","volume":"96","author":"Dispenzieri","year":"2021","journal-title":"Am. J. Hematol."},{"issue":"9","key":"10.1016\/j.heliyon.2023.e20612_bib13","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1001\/jamaoncol.2021.0586","article-title":"Update on the diagnosis and treatment of POEMS (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes) syndrome: a review","volume":"7","author":"Khouri","year":"2021","journal-title":"JAMA Oncol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e20612_bib14","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1182\/blood-2013-03-487025","article-title":"Outcomes of patients with POEMS syndrome treated initially with radiation","volume":"122","author":"Humeniuk","year":"2013","journal-title":"Blood"},{"issue":"24","key":"10.1016\/j.heliyon.2023.e20612_bib15","doi-asserted-by":"crossref","first-page":"6445","DOI":"10.1182\/blood-2010-12-328112","article-title":"Combination of melphalan and dexamethasone for patients with newly diagnosed POEMS syndrome","volume":"117","author":"Li","year":"2011","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.heliyon.2023.e20612_bib16","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/ajh.25100","article-title":"A prospective phase II study of low dose lenalidomide plus dexamethasone in patients with newly diagnosed polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome","volume":"93","author":"Li","year":"2018","journal-title":"Am. J. Hematol."},{"issue":"11","key":"10.1016\/j.heliyon.2023.e20612_bib17","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S1474-4422(16)30157-0","article-title":"Safety and efficacy of thalidomide in patients with POEMS syndrome: a multicentre, randomised, double-blind, placebo-controlled trial","volume":"15","author":"Misawa","year":"2016","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e20612_bib18","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/bjh.14497","article-title":"Successful treatment of newly diagnosed POEMS syndrome with reduced-dose bortezomib based regimen","volume":"181","author":"He","year":"2018","journal-title":"Br. J. Haematol."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e20612_bib19","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1600-0609.2009.01341.x","article-title":"Bortezomib: a new therapeutic option for POEMS syndrome","volume":"84","author":"Kaygusuz","year":"2010","journal-title":"Eur. J. Haematol."},{"issue":"8","key":"10.1016\/j.heliyon.2023.e20612_bib20","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1080\/10428194.2018.1564048","article-title":"Bortezomib-based regimens in patients with POEMS syndrome: a case series in newly diagnosed and relapsed patients","volume":"60","author":"Riva","year":"2019","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.heliyon.2023.e20612_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.670220","article-title":"Bibliometric analysis study on the mechanisms of brain energy metabolism disorders in alzheimer's disease from 2000 to 2020","volume":"12","author":"Du","year":"2021","journal-title":"Front. Neurol."},{"issue":"10","key":"10.1016\/j.heliyon.2023.e20612_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0223994","article-title":"Visualizing a field of research: a methodology of systematic scientometric reviews","volume":"14","author":"Chen","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2023.e20612_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.689553","article-title":"Mapping intellectual structures and research hotspots of triple negative Breast cancer: a bibliometric analysis","volume":"11","author":"Hao","year":"2022","journal-title":"Front. Oncol."},{"issue":"7","key":"10.1016\/j.heliyon.2023.e20612_bib24","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1182\/blood-2002-07-2299","article-title":"POEMS syndrome: definitions and long-term outcome","volume":"101","author":"Dispenzieri","year":"2003","journal-title":"Blood"},{"issue":"Pt 8","key":"10.1016\/j.heliyon.2023.e20612_bib25","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1093\/brain\/awh519","article-title":"Polyneuropathy in POEMS syndrome: role of angiogenic factors in the pathogenesis","volume":"128","author":"Scarlato","year":"2005","journal-title":"Brain"},{"issue":"11","key":"10.1016\/j.heliyon.2023.e20612_bib26","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1002\/ajh.23291","article-title":"The clinical spectrum of Castleman's disease","volume":"87","author":"Dispenzieri","year":"2012","journal-title":"Am. J. Hematol."},{"issue":"7","key":"10.1016\/j.heliyon.2023.e20612_bib27","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/ajh.25495","article-title":"POEMS Syndrome: 2019 Update on diagnosis, risk-stratification, and management","volume":"94","author":"Dispenzieri","year":"2019","journal-title":"Am. J. Hematol."},{"issue":"8","key":"10.1016\/j.heliyon.2023.e20612_bib28","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1182\/blood.V99.8.3057","article-title":"High-dose therapy and autologous blood stem cell transplantation in POEMS syndrome","volume":"99","author":"Jaccard","year":"2002","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.heliyon.2023.e20612_bib29","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1182\/blood-2004-05-2046","article-title":"Peripheral blood stem cell transplantation in 16 patients with POEMS syndrome, and a review of the literature","volume":"104","author":"Dispenzieri","year":"2004","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.heliyon.2023.e20612_bib30","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.blre.2007.07.004","article-title":"POEMS syndrome","volume":"21","author":"Dispenzieri","year":"2007","journal-title":"Blood Rev."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e20612_bib31","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1600-0609.2008.01037.x","article-title":"Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndrome","volume":"80","author":"Dispenzieri","year":"2008","journal-title":"Eur. J. Haematol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e20612_bib32","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1182\/blood-2012-04-423178","article-title":"Long-term outcomes after autologous stem cell transplantation for patients with POEMS syndrome (osteosclerotic myeloma): a single-center experience","volume":"120","author":"D'Souza","year":"2012","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.heliyon.2023.e20612_bib33","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/ajh.24802","article-title":"POEMS syndrome: 2017 Update on diagnosis, risk stratification, and management","volume":"92","author":"Dispenzieri","year":"2017","journal-title":"Am. J. Hematol."},{"issue":"7","key":"10.1016\/j.heliyon.2023.e20612_bib34","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/ajh.22050","article-title":"POEMS syndrome: 2011 update on diagnosis, risk-stratification, and management","volume":"86","author":"Dispenzieri","year":"2011","journal-title":"Am. J. Hematol."},{"issue":"8","key":"10.1016\/j.heliyon.2023.e20612_bib35","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/ajh.23288","article-title":"POEMS syndrome: update on diagnosis, risk-stratification, and management","volume":"87","author":"Dispenzieri","year":"2012","journal-title":"Am. J. Hematol."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e20612_bib36","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/ajh.23644","article-title":"POEMS syndrome: 2014 update on diagnosis, risk-stratification, and management","volume":"89","author":"Dispenzieri","year":"2014","journal-title":"Am. J. Hematol."},{"issue":"10","key":"10.1016\/j.heliyon.2023.e20612_bib37","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/ajh.24171","article-title":"POEMS syndrome: update on diagnosis, risk-stratification, and management","volume":"90","author":"Dispenzieri","year":"2015","journal-title":"Am. J. Hematol."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e20612_bib38","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1136\/jnnp-2020-324012","article-title":"Early VEGF testing in inflammatory neuropathy avoids POEMS syndrome misdiagnosis and associated costs","volume":"92","author":"Marsh","year":"2021","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"6","key":"10.1016\/j.heliyon.2023.e20612_bib39","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.3324\/haematol.2013.102962","article-title":"Markedly elevated serum total N-terminal propeptide of type I collagen is a novel marker for the diagnosis and follow up of patients with POEMS syndrome","volume":"99","author":"Wang","year":"2014","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.heliyon.2023.e20612_bib40","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/ajh.24356","article-title":"Long-term outcome of patients with POEMS syndrome: an update of the Mayo Clinic experience","volume":"91","author":"Kourelis","year":"2016","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.heliyon.2023.e20612_bib41","doi-asserted-by":"crossref","DOI":"10.1002\/ajh.27050","article-title":"Daratumumab monotherapy for relapsed POEMS syndrome","author":"Dima","year":"2023","journal-title":"Am. J. Hematol."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e20612_bib42","doi-asserted-by":"crossref","first-page":"E189","DOI":"10.1002\/ajh.26517","article-title":"Single-agent daratumumab for refractory POEMS syndrome","volume":"97","author":"Tiew","year":"2022","journal-title":"Am. J. Hematol."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e20612_bib43","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s12185-022-03459-w","article-title":"Daratumumab plus lenalidomide and dexamethasone for relapsed POEMS syndrome with bone plasmacytoma harboring 17p deletion","volume":"117","author":"Oyama","year":"2023","journal-title":"Int. J. Hematol."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e20612_bib44","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/jha2.492","article-title":"Daratumumab-bortezomib-dexamethasone use in relapsed POEMS syndrome","volume":"3","author":"Khwaja","year":"2022","journal-title":"EJHaem"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e20612_bib45","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s13045-018-0672-7","article-title":"Anti-BCMA CAR-T cells for treatment of plasma cell dyscrasia: case report on POEMS syndrome and multiple myeloma","volume":"11","author":"Xu","year":"2018","journal-title":"J. Hematol. Oncol."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023078209?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023078209?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:18:32Z","timestamp":1790756312000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844023078209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":45,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S2405844023078209"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e20612","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"POEMS syndrome in the 21st century: A bibliometric analysis","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e20612","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e20612"}}